What role does HPV play in the development of oropharyngeal squamous cell carcinoma?
HPV, especially type 16, is a major cause of oropharyngeal squamous cell carcinoma (OPSCC), a type of throat cancer. The virus's E6 and E7 proteins disable key tumor suppressor pathways, driving cancer formation. HPV-positive OPSCC is now recognized as a distinct disease with better prognosis and different treatment responses compared to HPV-negative tumors.
What the research says
The immune system plays a key role. Nearly all HPV-positive tumors contain HPV-specific T-cells, indicating an immune response 7. However, tumors may evade this response through various mechanisms 7. Epigenetic changes, such as DNA methylation, also differ between HPV-positive and HPV-negative tumors, contributing to their distinct behavior 8. These differences are being explored for personalized treatment 3.
What to ask your doctor
- What is the HPV status of my tumor, and how does it affect my prognosis and treatment options?
- Are there any clinical trials for HPV-positive OPSCC, especially those testing treatment de-escalation or immunotherapy?
- How does my tumor's immune environment or epigenetic profile influence my care?
- What are the potential long-term side effects of my treatment, and how can they be managed?
This question is drawn from common patient questions about Oncology and answered using cited medical research. We do not provide individualized advice.